Six Cycles of Doxorubicin and Cyclophosphamide or Paclitaxel Are Not Superior to Four Cycles As Adjuvant Chemotherapy for Breast Cancer in Women With Zero to Three Positive Axillary Nodes: Cancer and Leukemia Group B 40101

PURPOSE: The ideal duration of adjuvant chemotherapy for patients with lower risk primary breast cancer is not known. Cancer and Leukemia Group B trial 40101 was conducted using a phase III factorial design to define whether six cycles of a chemotherapy regimen are superior to four cycles. We also s...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Shulman, Lawrence N., Cirrincione, Constance T., Berry, Donald A., Becker, Heather P., Perez, Edith A., O'Regan, Ruth, Martino, Silvana, Atkins, James N., Mayer, Erica, Schneider, Charles J., Kimmick, Gretchen, Norton, Larry, Muss, Hyman, Winer, Eric P., Hudis, Clifford
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Clinical Oncology 2012
Fag:
ORIGINAL REPORTS
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3494835/
https://ncbi.nlm.nih.gov/pubmed/22826271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.40.6405
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker